Nonhuman Primate Reagent Resource for Translational Immunology
Official title: Nonhuman Primate Reagent Resource
Funded at Univ of Massachusetts Med Sch Worcester · NIH-11444851 · Data updated 2026-11-12
A national resource is being renewed to provide validated reagents tailored for nonhuman primates to support preclinical research in infectious diseases, transplantation, and immunotherapy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project start | September 29, 2016 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $1,300,000 |
| NIH project number | 2U24AI126683-11 |
| Project ID | NIH-11444851 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable (facility/resource for researchers; no direct patient enrollment)
✕Less likely to help
No direct patient participation; patients would not be recruited for this resource.
What this research studies
This grant funds a centralized resource that supplies high-quality, NHP-specific antibodies and related reagents to researchers. It emphasizes standardized characterization, traceability, and access to tools that better mimic human biology in preclinical studies. By sustaining and improving these reagents, scientists can perform more rigorous experiments that inform human therapeutics while reducing delays in translation.
Why it matters
Potential benefit: If successful, researchers will have reliable primate reagents to accelerate development of safe and effective human therapies.
How similar studies have gone: Previous NHPRR efforts have established a robust, widely used repository that improves preclinical study quality.
Where this research is happening
-
Univ of Massachusetts Med Sch Worcester
Worcester, United States Active
Researchers
- Principal investigator: Magnani, Diogo — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Magnani, Diogo
Related research
Other NIH-funded projects on the same topics.
-
Understanding HIV-1 Env shapes to boost immune attack against infected cells
Aimed at helping people living with HIV, this project explores how specific HIV-1 envelope structures attract or resist immune attack so future therapies could better help the body clear hidden virus.
-
Reprogramming metabolism to power alternative fat-burning modes
A new project will explore how fat cells burn calories in different ways to help combat obesity.
-
Silencing an Extra Chromosome to Help Down Syndrome and Related Conditions
A patient-friendly plan to use a gene-based approach to quiet an extra chromosome in cells and a mouse model to reduce disease-related effects in Down syndrome and other chromosomal imbalance disorders.
-
Gut microbes and brain function in autism
Researchers are exploring how gut bacteria may influence brain signals and behavior in autism, using worm models to uncover possible links that could someday inform human therapies.
-
Chlamydia and gonorrhea interaction: how host interferons influence co-infection
A human-health focused project looks at how the body’s interferon signals during chlamydia infection affect the way gonorrhea behaves, with potential implications for people vulnerable to both infections.
-
Conquering High Blood Pressure in Vietnamese Cities
A program to adapt and test a proven plan for lowering high blood pressure in urban Vietnam using a mobile health platform and integrated care approach.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.